• 23. November 2024

Daiichi Sankyo to Present Findings From New Subgroup Analyses of Once-Daily LIXIANA® (edoxaban) in NVAF and VTE at ACC’s 65th Annual Scientific Session


Teile den Beitrag mit Freunden